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SUMMARY. In this study, blood samples of rabbits were collected to measure plasma total cholesterol, to-
tal triglyceride, and LDL-cholesterol. After 16 weeks of high cholesterol diet with or without atorvastatin
treatment, the rabbits were sacrificed and morphological changes in tissues were examined with hema-
toxylin and eosin (HE) staining, and the expression of vascular-cell adhesion molecule 1 (VCAM-1) was
determined by immunostaining and reverse transcription-polymerase chain reaction (RT-PCR). We
demonstrate that atorvastatin significantly reduced plasma levels of total cholesterol (41.7 %) and LDL-
cholesterol (34.6 %). Neither the hyper cholesterol diet nor atorvastatin treatment had any significant im-
pact on body weight and plasma triglycerides (TG). Atorvastatin significantly restored the intima with
widening of 40.9 % and even down-regulated the ratio of intima/media by 55.5 %. The inhibitory effects of
atorvastatin on the expression of VCAM-1 showed a decrease of up to 46.9 % (P < 0.01). The diseased rab-
bits showed a 63.2 % increase in VCAM-1 mRNA expression (P < 0.01), which was reversed by nearly 60
% by treatment with atorvastatin.
